Victor García-González

14PUBLICATIONS
31CO-AUTHORS
Molecular targetsCancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 27, 2026
Nrf2 Is Associated with Metastasis-Related Processes in a Chemoresistant Breast Cancer Model: Insights from siRNA Modulation.

|Jan 07, 2026
The transition from preclinical to clinical obesity: the importance of a borderline stage.

Jesus E Maldonado-Arvizu, Paula Vanessa Rios-Verdugo, José Fernando Díaz-Villanueva

|Aug 28, 2025
Vitamin D as an Epigenetic Regulator: A Hypothetical Mechanism for Cancer Prevention via Inhibition of Oncogenic lncRNA HOTAIR.

Samuel Trujano-Camacho, Ángel Pulido-Capiz, Victor García-González

|May 07, 2025
Lapatinib-Resistant HER2+ Breast Cancer Cells Are Associated with Dysregulation of MAPK and p70S6K/PDCD4 Pathways and Calcium Management, Influence of Cryptotanshinone.

Jorge Hernández-Valencia, Ruth García-Villarreal, Manuel Rodríguez-Jiménez

|Sep 28, 2024
Auraptene Boosts the Efficacy of the Tamoxifen Metabolites Endoxifen and 4-OH-Tamoxifen in a Chemoresistant ER+ Breast Cancer Model.

Angel Pulido-Capiz, Brenda Chimal-Vega, Luis Pablo Avila-Barrientos

|Apr 27, 2024
Low-Density Lipoproteins Increase Proliferation, Invasion, and Chemoresistance via an Exosome Autocrine Mechanism in MDA-MB-231 Chemoresistant Cells.

César Y Castañeda-Sánchez, Brenda Chimal-Vega, Roberto León-Gutiérrez

Pageof 3

Frequent Collaborators

8 joint publications

Octavio Galindo-Hernández

7 joint publications

Raúl Díaz-Molina

6 joint publications

Ángel Pulido-Capiz

4 joint publications

Nicolás Serafín-Higuera